Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference

 Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference

PR Newswire

THOUSAND OAKS, Calif., March 1, 2013

THOUSAND OAKS, Calif., March 1, 2013 /PRNewswire/ --Amgen (NASDAQ:AMGN) will
present at the Cowen and Company 33^rd Annual Health Care Conference on
Wednesday, March 6, 2013, at the Boston Marriott Copley Place, Boston, Mass.,
beginning at 9:20 a.m. EST. Arvind Sood, vice president of Investor Relations
at Amgen, will present at the conference. Live audio of the presentation can
be accessed from the Events Calendar on Amgen's website,, under
Investors. A replay of the webcast will also be available on Amgen's website
for 90 days following the event.


About Amgen

Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and effective
medicines from lab, to manufacturing plant, to patient. Amgen therapeutics
have changed the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid arthritis, bone
disease and other serious illnesses. With a deep and broad pipeline of
potential new medicines, Amgen remains committed to advancing science to
dramatically improve people's lives. To learn more about our pioneering
science and our vital medicines, visit Follow us on

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Eric Hyllengren, 805-447-1060 (investors)


Press spacebar to pause and continue. Press esc to stop.